Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening

Jaffar Alfardan, Al Walid Mohsen, Sara Copeland, Jay Ellison, Laura Keppen-Davis, Marianne Rohrbach, Berkley R. Powell, Jane Gillis, Dietrich Matern, Jeffrey Kant, Jerry Vockley

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Short/branched chain acyl-CoA dehydrogenase (SBCAD) deficiency, also known as 2-methylbutyryl-CoA dehydrogenase deficiency, is a recently described autosomal recessive disorder of isoleucine metabolism. Most patients reported thus far have originated from a founder mutation in the Hmong Chinese population. While the first reported patients had severe disease, most of the affected Hmong have remained asymptomatic. In this study, we describe 11 asymptomatic non-Hmong patients brought to medical attention by elevated C5-carnitine found by newborn screening and one discovered because of clinical symptoms. The diagnosis of SBCAD deficiency was determined by metabolite analysis of blood, urine, and fibroblast samples. PCR and bidirectional sequencing were performed on genomic DNA from five of the patients covering the entire SBCAD (ACADSB) gene sequence of 11 exons. Sequence analysis of genomic DNA from each patient identified variations in the SBCAD gene not previously reported. Escherichia coli expression studies revealed that the missense mutations identified lead to inactivation or instability of the mutant SBCAD enzymes. These findings confirm that SBCAD deficiency can be identified through newborn screening by acylcarnitine analysis. Our patients have been well without treatment and call for careful follow-up studies to learn the true clinical impact of this disorder.

Original languageEnglish (US)
Pages (from-to)333-338
Number of pages6
JournalMolecular Genetics and Metabolism
Volume100
Issue number4
DOIs
StatePublished - Aug 2010

Fingerprint

Butyryl-CoA Dehydrogenase
Screening
Genes
Newborn Infant
Mutation
Carnitine
Isoleucine
DNA
Missense Mutation
Coenzyme A
Fibroblasts
Metabolites
DNA Sequence Analysis
Metabolism
Escherichia coli
2-methylacyl-CoA dehydrogenase
Exons
Oxidoreductases
Blood
Urine

Keywords

  • 2-Methylbutyryl coenzyme A dehydrogenase
  • Acyl-CoA dehydrogenase
  • Branched chain acyl coenzyme A dehydrogenase
  • Isoleucine metabolism
  • Newborn screening
  • Organic acidemia

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening. / Alfardan, Jaffar; Mohsen, Al Walid; Copeland, Sara; Ellison, Jay; Keppen-Davis, Laura; Rohrbach, Marianne; Powell, Berkley R.; Gillis, Jane; Matern, Dietrich; Kant, Jeffrey; Vockley, Jerry.

In: Molecular Genetics and Metabolism, Vol. 100, No. 4, 08.2010, p. 333-338.

Research output: Contribution to journalArticle

Alfardan, J, Mohsen, AW, Copeland, S, Ellison, J, Keppen-Davis, L, Rohrbach, M, Powell, BR, Gillis, J, Matern, D, Kant, J & Vockley, J 2010, 'Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening', Molecular Genetics and Metabolism, vol. 100, no. 4, pp. 333-338. https://doi.org/10.1016/j.ymgme.2010.04.014
Alfardan, Jaffar ; Mohsen, Al Walid ; Copeland, Sara ; Ellison, Jay ; Keppen-Davis, Laura ; Rohrbach, Marianne ; Powell, Berkley R. ; Gillis, Jane ; Matern, Dietrich ; Kant, Jeffrey ; Vockley, Jerry. / Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening. In: Molecular Genetics and Metabolism. 2010 ; Vol. 100, No. 4. pp. 333-338.
@article{ce2f8bb513d846b48641ee354119db4f,
title = "Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening",
abstract = "Short/branched chain acyl-CoA dehydrogenase (SBCAD) deficiency, also known as 2-methylbutyryl-CoA dehydrogenase deficiency, is a recently described autosomal recessive disorder of isoleucine metabolism. Most patients reported thus far have originated from a founder mutation in the Hmong Chinese population. While the first reported patients had severe disease, most of the affected Hmong have remained asymptomatic. In this study, we describe 11 asymptomatic non-Hmong patients brought to medical attention by elevated C5-carnitine found by newborn screening and one discovered because of clinical symptoms. The diagnosis of SBCAD deficiency was determined by metabolite analysis of blood, urine, and fibroblast samples. PCR and bidirectional sequencing were performed on genomic DNA from five of the patients covering the entire SBCAD (ACADSB) gene sequence of 11 exons. Sequence analysis of genomic DNA from each patient identified variations in the SBCAD gene not previously reported. Escherichia coli expression studies revealed that the missense mutations identified lead to inactivation or instability of the mutant SBCAD enzymes. These findings confirm that SBCAD deficiency can be identified through newborn screening by acylcarnitine analysis. Our patients have been well without treatment and call for careful follow-up studies to learn the true clinical impact of this disorder.",
keywords = "2-Methylbutyryl coenzyme A dehydrogenase, Acyl-CoA dehydrogenase, Branched chain acyl coenzyme A dehydrogenase, Isoleucine metabolism, Newborn screening, Organic acidemia",
author = "Jaffar Alfardan and Mohsen, {Al Walid} and Sara Copeland and Jay Ellison and Laura Keppen-Davis and Marianne Rohrbach and Powell, {Berkley R.} and Jane Gillis and Dietrich Matern and Jeffrey Kant and Jerry Vockley",
year = "2010",
month = "8",
doi = "10.1016/j.ymgme.2010.04.014",
language = "English (US)",
volume = "100",
pages = "333--338",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening

AU - Alfardan, Jaffar

AU - Mohsen, Al Walid

AU - Copeland, Sara

AU - Ellison, Jay

AU - Keppen-Davis, Laura

AU - Rohrbach, Marianne

AU - Powell, Berkley R.

AU - Gillis, Jane

AU - Matern, Dietrich

AU - Kant, Jeffrey

AU - Vockley, Jerry

PY - 2010/8

Y1 - 2010/8

N2 - Short/branched chain acyl-CoA dehydrogenase (SBCAD) deficiency, also known as 2-methylbutyryl-CoA dehydrogenase deficiency, is a recently described autosomal recessive disorder of isoleucine metabolism. Most patients reported thus far have originated from a founder mutation in the Hmong Chinese population. While the first reported patients had severe disease, most of the affected Hmong have remained asymptomatic. In this study, we describe 11 asymptomatic non-Hmong patients brought to medical attention by elevated C5-carnitine found by newborn screening and one discovered because of clinical symptoms. The diagnosis of SBCAD deficiency was determined by metabolite analysis of blood, urine, and fibroblast samples. PCR and bidirectional sequencing were performed on genomic DNA from five of the patients covering the entire SBCAD (ACADSB) gene sequence of 11 exons. Sequence analysis of genomic DNA from each patient identified variations in the SBCAD gene not previously reported. Escherichia coli expression studies revealed that the missense mutations identified lead to inactivation or instability of the mutant SBCAD enzymes. These findings confirm that SBCAD deficiency can be identified through newborn screening by acylcarnitine analysis. Our patients have been well without treatment and call for careful follow-up studies to learn the true clinical impact of this disorder.

AB - Short/branched chain acyl-CoA dehydrogenase (SBCAD) deficiency, also known as 2-methylbutyryl-CoA dehydrogenase deficiency, is a recently described autosomal recessive disorder of isoleucine metabolism. Most patients reported thus far have originated from a founder mutation in the Hmong Chinese population. While the first reported patients had severe disease, most of the affected Hmong have remained asymptomatic. In this study, we describe 11 asymptomatic non-Hmong patients brought to medical attention by elevated C5-carnitine found by newborn screening and one discovered because of clinical symptoms. The diagnosis of SBCAD deficiency was determined by metabolite analysis of blood, urine, and fibroblast samples. PCR and bidirectional sequencing were performed on genomic DNA from five of the patients covering the entire SBCAD (ACADSB) gene sequence of 11 exons. Sequence analysis of genomic DNA from each patient identified variations in the SBCAD gene not previously reported. Escherichia coli expression studies revealed that the missense mutations identified lead to inactivation or instability of the mutant SBCAD enzymes. These findings confirm that SBCAD deficiency can be identified through newborn screening by acylcarnitine analysis. Our patients have been well without treatment and call for careful follow-up studies to learn the true clinical impact of this disorder.

KW - 2-Methylbutyryl coenzyme A dehydrogenase

KW - Acyl-CoA dehydrogenase

KW - Branched chain acyl coenzyme A dehydrogenase

KW - Isoleucine metabolism

KW - Newborn screening

KW - Organic acidemia

UR - http://www.scopus.com/inward/record.url?scp=77954660920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954660920&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2010.04.014

DO - 10.1016/j.ymgme.2010.04.014

M3 - Article

C2 - 20547083

AN - SCOPUS:77954660920

VL - 100

SP - 333

EP - 338

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -